ReviewAIDS (London, England)2026

Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV.

Giuseppe Lapadula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.